STOCK TITAN

Chiliz Group boosts Processa (PCSA) stake to 13% with added share buy

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

The Chiliz Group Ltd, formerly HX Entertainment, reports a 13.0% beneficial ownership stake in Processa Pharmaceuticals’ common stock. It holds 305,644 shares with sole voting and dispositive power. This reflects its role as a significant strategic investor in the company.

The Chiliz Group’s total investment of approximately $1,443,784 includes an August 2025 purchase (later adjusted by a 1-for-25 reverse split) and a new February 13, 2026 purchase of 86,956 shares at $2.30 per share for $200,000, funded from internal working capital.

Positive

  • None.

Negative

  • None.

Insights

Chiliz Group solidifies a 13% stake in Processa, reinforcing its role as a key shareholder.

The filing shows The Chiliz Group now beneficially owns 305,644 Processa shares, or 13.0% of the common stock, with sole voting and dispositive power. This confirms a concentrated outside shareholder with meaningful influence potential relative to the company’s equity base.

The aggregate investment of about $1,443,784, including a fresh $200,000 restricted-share purchase on February 13, 2026, is funded from the group’s working capital, with no leverage disclosed. Subsequent ownership changes or additional agreements, if any, would typically appear in later regulatory disclosures.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D


HX Entertainment Ltd
Signature:X
Name/Title:Alexandre Dreyfus
Date:02/19/2026

FAQ

What ownership stake does The Chiliz Group hold in Processa Pharmaceuticals (PCSA)?

The Chiliz Group beneficially owns 305,644 shares of Processa common stock, representing about 13.0% of the company’s outstanding shares. This percentage is based on the issuer’s adjusted share count after a 1-for-25 reverse stock split and the latest share issuance.

How much has The Chiliz Group invested in Processa Pharmaceuticals (PCSA) shares?

The Chiliz Group reports an aggregate purchase price of approximately $1,443,784 for its Processa stake. This includes an August 2025 share purchase later adjusted by a reverse split and a February 13, 2026 acquisition of 86,956 shares at $2.30 per share for $200,000.

What recent transaction did The Chiliz Group complete in Processa Pharmaceuticals (PCSA) stock?

On February 13, 2026, The Chiliz Group purchased 86,956 Processa common shares at $2.30 per share, totaling $200,000. This was done under a Securities Purchase Agreement with the issuer, involving restricted securities funded from the group’s own working capital and investment funds.

Does The Chiliz Group control how its Processa Pharmaceuticals (PCSA) shares are voted and sold?

Yes. The Chiliz Group reports sole voting power and sole dispositive power over 305,644 Processa common shares. This means it alone decides how these shares are voted and whether, when, and how they might be sold or otherwise transferred, absent additional arrangements.

How was the 13.0% ownership in Processa Pharmaceuticals (PCSA) calculated for The Chiliz Group?

The 13.0% figure is based on 56,644,223 shares outstanding as of November 3, 2025, adjusted for a 1-for-25 reverse split to about 2,265,769 shares, then further adjusted to include 86,956 new shares issued to The Chiliz Group, yielding an estimated 2,352,725 shares outstanding.

What is the purpose of The Chiliz Group’s investment in Processa Pharmaceuticals (PCSA)?

The filing states there is no material change from the previously disclosed purpose. The additional investment is consistent with The Chiliz Group’s earlier described investment purpose and strategic interest in Processa, rather than indicating a new or different strategic objective at this time.